News
Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA
Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy,...
News
New Zealand approves use of Pfizer-BioNtech’s Covid-19 vaccine
The New Zealand Government has granted formal approval for use of Pfizer and BioNTech’s Covid-19 vaccine as a critical step to ensure the vaccine...
News
Pfizer and IDA Foundation Partner to Expand Access to Essential Cancer Treatments in 70 Low- and Lower-Middle-Income Countries
Pfizer announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access to quality...
News
PHARMASEAL’s Engility platform fights off competition to be selected by award-winning US Medical Device company
PHARMASEAL, a provider of clinical trial management and governance solutions, announced today that it has secured its first Medical Device customer – an award-winning...
News
Global rare disease specialist Raremark appoints healthtech trailblazer Dale Jessop as new CTO
Raremark®, the global healthtech company specializing in rare disease, has today announced the appointment of Dale Jessop as Chief Technical Officer.
Jessop brings a wealth...
Press Releases
HKSTP and AstraZeneca Launch Co-incubation Programme for Biomedical Startups to Develop Made in HK Integrated Oncology Solutions
AstraZeneca and the Hong Kong Science and Technology Parks Corporation (HKSTP) have launched a co-incubation programme to support biomedical startups in their mission to...
News
AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products
AbbVie and Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced that they have entered into a collaboration and license agreement...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read